Sprint Bioscience AB (5JA1)
FSX
Real-time Data
06:00 AM
Day's Range
0.232052 wk Range
0.0306Overview - 5JA1 - Sprint Bioscience AB
Key Statistics
Valuation
P/E (Trailing)
‪3.37‬
PEG Ratio
‪0.03‬
Price / Sales (TTM)
‪0.15‬
Price / Book
‪4.73‬
Profitability
Profit Margin
‪54.44%‬
Operating Margin
‪55.13%‬
Return on Assets
‪68.66%‬
Return on Equity
‪144.94%‬
Ownership
Shares Outstanding
105.51M
Float
72.25M
Held by Insiders
‪27.84%‬
Held by Institutions
‪40.63%‬
Price stats
50-Day Avg
‪0.3022‬
200-Day Avg
‪0.2336‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 5JA1 - Sprint Bioscience AB
Peers - 5JA1 - Sprint Bioscience AB
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- 5JA1FSXSprint Bioscience AB25.11MMarket Cap+85.38%52-week change3.38P/E (Trailing)‪54.44%‬Profit Margin
- ANLFSXAnalog Devices Inc.151.88BMarket Cap+35.24%52-week change43.41P/E (Trailing)‪29.78%‬Profit Margin
- 1AEFSXargenx SE52.93BMarket Cap+23.73%52-week change38.15P/E (Trailing)‪32.26%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt51.30BMarket Cap+24.85%52-week change36.06P/E (Trailing)‪32.26%‬Profit Margin
- 0QFFSXModerna Inc.50.90BMarket Cap+83.96%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 64BFSXAstera Labs, Inc.38.16BMarket Cap+25.45%52-week change136.57P/E (Trailing)‪30.74%‬Profit Margin
- 42ZFSXRevolution Medicines, Inc.37.64BMarket Cap+77.80%52-week change-29.52P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - 5JA1 - Sprint Bioscience AB
About
Sprint Bioscience AB is a biotechnology company specializing in the early stages of drug development. The company's primary function is to accelerate the discovery and development of novel oncology pharmaceuticals. Utilizing state-of-the-art technology platforms, Sprint Bioscience focuses on identifying and validating…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
